ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

NCI Initiative: Start With Mechanism, Then answer The Many Questions, Klauser Says to Advisors

November 29, 1996

Also in this 12-page issue: Senate report endorses NCI’s 2015 goal.

July 22, 2005

Nine contracts For Automated Pap Test Systems Total $1.7 Million

October 18, 1974

President to Propose 2 Percent Increase in NIH Budge, Slowing Funding Growth

January 15, 1999